tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RNA Stock Latest News

Avidity Biosciences’ Promising Developments in DMD Treatment and Strategic Preparations for Future Success
RatingsAvidity Biosciences’ Promising Developments in DMD Treatment and Strategic Preparations for Future Success
12d ago
RNA
Buy Rating for Avidity Biosciences Driven by Strategic Leadership and Patient-Centric Approach
PremiumRatings
Buy Rating for Avidity Biosciences Driven by Strategic Leadership and Patient-Centric Approach
12d ago
RNA
Avidity Biosciences: Strategic Advancements in DMD Program and Promising Market Potential Justify Buy Rating
PremiumRatings
Avidity Biosciences: Strategic Advancements in DMD Program and Promising Market Potential Justify Buy Rating
13d ago
RNA
Optimistic Buy Rating for Avidity Biosciences Driven by Promising DMD Treatment and Strategic Expansion Plans
PremiumRatings
Optimistic Buy Rating for Avidity Biosciences Driven by Promising DMD Treatment and Strategic Expansion Plans
13d ago
RNA
Promising Trial Results and Strong Growth Potential Lead to Buy Rating for Avidity Biosciences
PremiumRatings
Promising Trial Results and Strong Growth Potential Lead to Buy Rating for Avidity Biosciences
13d ago
RNA
Avidity Biosciences: Promising Trial Data and Future Prospects Justify Buy Rating
PremiumRatingsAvidity Biosciences: Promising Trial Data and Future Prospects Justify Buy Rating
13d ago
RNA
Avidity Biosciences Announces Positive EXPLORE44 Trial Results
Premium
Company Announcements
Avidity Biosciences Announces Positive EXPLORE44 Trial Results
14d ago
8K
RNA
Avidity Biosciences announces del-zota topline data from EXPLORE44 trial
Premium
The Fly
Avidity Biosciences announces del-zota topline data from EXPLORE44 trial
14d ago
RNA
Avidity Biosciences announces ‘positive’ data from Phase 1/2 EXPLORE44 trial
PremiumThe Fly
Avidity Biosciences announces ‘positive’ data from Phase 1/2 EXPLORE44 trial
14d ago
RNA
Avidity Biosciences initiated with a Buy at Citi
PremiumThe Fly
Avidity Biosciences initiated with a Buy at Citi
18d ago
RNA
Avidity Biosciences: Promising Pipeline and Strategic Positioning Drive Buy Rating
PremiumRatings
Avidity Biosciences: Promising Pipeline and Strategic Positioning Drive Buy Rating
19d ago
RNA
Avidity Biosciences initiated with an Outperform at BMO Capital
PremiumThe Fly
Avidity Biosciences initiated with an Outperform at BMO Capital
19d ago
RNA
Avidity Biosciences price target lowered to $48 from $51 at BofA
PremiumThe FlyAvidity Biosciences price target lowered to $48 from $51 at BofA
20d ago
RNA
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
Premium
The Fly
Tesla upgraded, Coinbase initiated: Wall Street’s top analyst calls
23d ago
W
AL
Avidity Biosciences initiated with an Outperform at Scotiabank
Premium
The Fly
Avidity Biosciences initiated with an Outperform at Scotiabank
24d ago
RNA
Avidity Biosciences: Positioned for Transformative Growth with Promising Pipeline and Strategic Launch Preparations
PremiumRatings
Avidity Biosciences: Positioned for Transformative Growth with Promising Pipeline and Strategic Launch Preparations
28d ago
RNA
Avidity Biosciences Advances RNA Therapeutics for Rare Diseases
PremiumCompany Announcements
Avidity Biosciences Advances RNA Therapeutics for Rare Diseases
30d ago
RNA
Positive Outlook for Avidity Biosciences Driven by Promising Pipeline Developments and Strong Financial Position
PremiumRatings
Positive Outlook for Avidity Biosciences Driven by Promising Pipeline Developments and Strong Financial Position
1M ago
RNA
Avidity Biosciences: Promising Drug Pipeline and Potential Approval for DMD44 Drive Buy Rating
PremiumRatings
Avidity Biosciences: Promising Drug Pipeline and Potential Approval for DMD44 Drive Buy Rating
1M ago
RNA
Avidity Biosciences price target lowered to $57 from $63 at Barclays
PremiumThe FlyAvidity Biosciences price target lowered to $57 from $63 at Barclays
1M ago
RNA
Avidity Biosciences: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
Premium
Ratings
Avidity Biosciences: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
1M ago
RNA
Avidity Biosciences reports Q4 EPS (80c), consensus (78c)
Premium
The Fly
Avidity Biosciences reports Q4 EPS (80c), consensus (78c)
1M ago
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >